All Posts By

Smartkarma Daily Briefs

Daily Brief Health Care: Ebos Group Ltd, Shanghai Medicilon Inc, Amgen Inc and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Index Rebalance & ETF Flow Recap: MSCI, CSI500, XIN9I, DTAC/TRUE, Newcrest, Adani, Korea Spinoffs
  • China Healthcare Weekly (Feb.10) – Assisted Reproduction into NRDL, Cell Therapy, Medicilon, IRay,
  • Amgen Inc: Acquisition Of Horizon Therapeutics & Other Drivers

Index Rebalance & ETF Flow Recap: MSCI, CSI500, XIN9I, DTAC/TRUE, Newcrest, Adani, Korea Spinoffs

By Brian Freitas

  • MSCI announced the changes to the GIMI on Friday as part of the February QCIR. MSCI also announced a review of the free float of the Adani Group companies.
  • FTSE will announce the changes to the All-World and All-Cap indices after the close of trading on Friday, 17 February. The same day is the S&P/ASX review cutoff for March.
  • Yet another weekly outflow for the IShares Edge MSCI Min Vol Emerging Markets ETF (EEMV US) taking the YTD outflow to over US$2.5bn.

China Healthcare Weekly (Feb.10) – Assisted Reproduction into NRDL, Cell Therapy, Medicilon, IRay,

By Xinyao (Criss) Wang

  • The benefits of assisted reproduction being covered by medical insurance are limited. Its main role is still to delay not fundamentally reverse the decline of China’s birth rate.
  • If the valuation collapse occurs collectively in one field, it basically reflects that Miss Market does not hold much hope for this field in the future, such as cell therapy. 
  • We mainly analyzed some key points of the companies that investors may be interested in, such as iRay Technology (688301 CH) and Shanghai Medicilon Inc (688202 CH).

Amgen Inc: Acquisition Of Horizon Therapeutics & Other Drivers

By Baptista Research

  • The company carried out some major acquisitions in the year including the $3.7 billion purchase of ChemoCentryx followed by the even bigger, $27.8 billion acquisition of Horizon Therapeutics.
  • Their portfolio will also grow due to the addition of Horizon Therapeutics.
  • In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Sebang Co Ltd, Jgc Corp, Tokyo Electron, Toshiba Corp and more

By | Daily Briefs, Industrials

In today’s briefing:

  • KOSPI Size Index Migration: Names to Trade as We Are 30D Towards Effective
  • JGC (1963 JP) – A ToSTNeT Buyback Is NOT a ToSTNeT Buyback and Adjusted EV Vs Adjusted EBITDA Is OK.
  • Tokyo Electron (8035 JP): MAGIC Versus Reality
  • Last Week in SPACE: Adani Group, Hongkong Land, Toshiba, Haw Par, Renault/Nissan
  • Weekly Deals Digest (12 Feb) – Pertamina Geothermal, Toshiba, Newcrest, Nitro, Boustead, Sabana

KOSPI Size Index Migration: Names to Trade as We Are 30D Towards Effective

By Sanghyun Park

  • Amorepacific Group is more likely to remain in LargeCap due to its share price surge earlier this year. Instead, Hyundai Autoever will likely face a large→mid migration.
  • Of Small→Mid migrants. Sebang and Kum Yang deserve attention, as they will rank high in the Mid due to the rapid market cap growth over the past six months.
  • YTD performance seems to have a higher correlation with individual sector performance than causality with this event. So, there is still a circumstantial probability that justifies the trade.

JGC (1963 JP) – A ToSTNeT Buyback Is NOT a ToSTNeT Buyback and Adjusted EV Vs Adjusted EBITDA Is OK.

By Travis Lundy

  • Engineering & Construction firm Jgc Corp (1963 JP) on Friday announced 9M results. Full-Year forecasts were revised, with revenue lowered, but OP, RP, and NP unchanged.
  • The company then also announced a ToSTNeT-3 buyback of up to 4.77% of shares out for ¥20bn to be executed Monday 13 February pre-open. But details matter. 
  • Four Important Takeaways: 1) sometimes a ToSTNeT-3 buyback is not a ToSTNeT-3 buyback, 2) that can be a good sign, and 3) sometimes Adjusted EV vs Adjusted EBITDA is OK.

Tokyo Electron (8035 JP): MAGIC Versus Reality

By Scott Foster

  • The market welcomed TEL’s 3Q results and new guidance, but sales, profits and margins continue to decline year-on-year.
  • An optimistic consensus sees a new cyclical high in the second half of the decade, but avoids the question of disengagement from China.
  • Inventories are at a record high. Valuations out to FY Mar-25 do not look attractive. 

Last Week in SPACE: Adani Group, Hongkong Land, Toshiba, Haw Par, Renault/Nissan

By David Blennerhassett


Weekly Deals Digest (12 Feb) – Pertamina Geothermal, Toshiba, Newcrest, Nitro, Boustead, Sabana

By Arun George


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Tencent, Hong Kong Hang Seng Index, Shanghai Medicilon Inc and more

By | China, Daily Briefs

In today’s briefing:

  • ECM Weekly (12th Feb 2023) – Hesai, Oasis, Mankind, Greatpower, Ruipeng, CATL, Nissan/Renault
  • EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades
  • China Healthcare Weekly (Feb.10) – Assisted Reproduction into NRDL, Cell Therapy, Medicilon, IRay,

ECM Weekly (12th Feb 2023) – Hesai, Oasis, Mankind, Greatpower, Ruipeng, CATL, Nissan/Renault

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, Hesai Group (HSAI US) provided the first Asia linked listing for the year.
  • Things were quiet on the placement front owing to the annual earnings reporting season.

EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades

By Simon Harris

  • Weekly summary of vol changes and moves across Global Markets
  • Analysing ATM volatility and skew changes over the last 5 days
  • We suggest a few trades to take advantage of the implied vol surfaces

China Healthcare Weekly (Feb.10) – Assisted Reproduction into NRDL, Cell Therapy, Medicilon, IRay,

By Xinyao (Criss) Wang

  • The benefits of assisted reproduction being covered by medical insurance are limited. Its main role is still to delay not fundamentally reverse the decline of China’s birth rate.
  • If the valuation collapse occurs collectively in one field, it basically reflects that Miss Market does not hold much hope for this field in the future, such as cell therapy. 
  • We mainly analyzed some key points of the companies that investors may be interested in, such as iRay Technology (688301 CH) and Shanghai Medicilon Inc (688202 CH).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Most Read: Surya Esa Perkasa, Jiangxi Special Electric Motor A, S.M.Entertainment Co, Link REIT, Sabana Industrial REIT, Kakao Pay, Sebang Co Ltd, Ebos Group Ltd, Jgc Corp and more

By | Daily Briefs, Most Read

In today’s briefing:

  • IDX30/​​LQ45/IDX80 Index Rebalance: 4 Days to Implementation
  • Index Rebalance & ETF Flow Recap: MSCI, ASX, STAR50, China 50, NIFTY100, SMM SP, Pertamina Geo IPO
  • CSI500 Index Rebalance Preview: Potential Adds Continuing to Outperform
  • HYBE to Acquire a 39.8% Stake in SM Entertainment
  • Big Link REIT (823 HK) Rights Offering
  • Sabana Industrial REIT – Offer Goes Live, Worth A Look
  • MSCI Korea Index Rebalance: Kakao Pay Included
  • KOSPI Size Index Migration: Names to Trade as We Are 30D Towards Effective
  • Index Rebalance & ETF Flow Recap: MSCI, CSI500, XIN9I, DTAC/TRUE, Newcrest, Adani, Korea Spinoffs
  • JGC (1963 JP) – A ToSTNeT Buyback Is NOT a ToSTNeT Buyback and Adjusted EV Vs Adjusted EBITDA Is OK.

IDX30/​​LQ45/IDX80 Index Rebalance: 4 Days to Implementation

By Brian Freitas

  • There are 3 changes for the IDX30 Index, 6 changes for the LQ45 Index, and 7 changes for the IDX80 Index at the rebalance to be implemented on 31 January.
  • Largest passive inflows are expected to be on Sumber Alfaria Trijaya Tbk Pt (AMRT IJ) and Surya Esa Perkasa (ESSA IJ)
  • With only 4 days to implementation, there will be relatively big moves on stocks that have large flow/impact from passive fund trading.

Index Rebalance & ETF Flow Recap: MSCI, ASX, STAR50, China 50, NIFTY100, SMM SP, Pertamina Geo IPO

By Brian Freitas


CSI500 Index Rebalance Preview: Potential Adds Continuing to Outperform

By Brian Freitas

  • Three quarters of the way through the review period for the June rebalance of the CSI500 Index, we forecast 50 changes (the maximum permitted) at the close on 9 June.
  • There is a big sector skew in the potential changes. We estimate a one-way turnover of 11.47% at the June rebalance resulting in a one-way trade of CNY 10.11bn.
  • The potential adds have outperformed the potential deletes and the CSI500 Index over the last few weeks. There could be more outperformance till nearer the end of the review period.

HYBE to Acquire a 39.8% Stake in SM Entertainment

By Douglas Kim

  • On 10 February (prior to market open), Seoul Economic Daily reported that HYBE will conduct a tender offer of SM Entertainment shares taking over the controlling ownership of the company.
  • HYBE agreed to acquire a 14.8% stake from SM Entertainment’s founder Lee Soo-Man at 120,000 won per share, which represents a 21.8% premium to the closing price on 9 February.
  • HYBE is also conducting a tender offer to minority shareholders and it plans to acquire up to 25% additional shares at 120,000 won per share, representing 717 billion won.

Big Link REIT (823 HK) Rights Offering

By Travis Lundy

  • After being halted this morning before the start of trade, post-close, Link REIT (823 HK) announced a fully-underwritten Rights Offering
  • The Rights Offering intends to raise HK$18.8bn issuing 1 Right for every 5 Shares held, at a subscription price of HK$44.20, a 26% discount to TERP. 
  • This will take an already under-levered REIT and add more capital to it. And there is going to be selling pressure at some point.

Sabana Industrial REIT – Offer Goes Live, Worth A Look

By Travis Lundy

  • The Sabana Industrial REIT (SSREIT SP) 2022H2 dividend went ex- on 6 February 2023, setting the Offer to be lowered. The Offer by Volare was lowered. Docs out Friday night.
  • The S$0.465 Offer, adjusted for dividends (to be paid 27 March (cash or DRP units)), is now S$0.4504 per unit. The first close is 10 March 2023. 
  • Sabana has underperformed a basket of slightly higher beta peers by 1+% since the day before the announcement. Watch pro-ration risk.

MSCI Korea Index Rebalance: Kakao Pay Included

By Douglas Kim

  • MSCI announced its MSCI Korea index rebalance on 10 February. Kakao Pay (377300 KS) was the only company to be included in the MSCI Korea index.
  • There were also nine Korean companies included in MSCI Small Cap index including Osstem Implant, DearU, and ISC Co. 
  • Hanwha Aerospace (012450 KS) and Ecopro Co Ltd (086520 KS) are higher probability potential candidates for inclusion in MSCI Korea Index rebalance in May. 

KOSPI Size Index Migration: Names to Trade as We Are 30D Towards Effective

By Sanghyun Park

  • Amorepacific Group is more likely to remain in LargeCap due to its share price surge earlier this year. Instead, Hyundai Autoever will likely face a large→mid migration.
  • Of Small→Mid migrants. Sebang and Kum Yang deserve attention, as they will rank high in the Mid due to the rapid market cap growth over the past six months.
  • YTD performance seems to have a higher correlation with individual sector performance than causality with this event. So, there is still a circumstantial probability that justifies the trade.

Index Rebalance & ETF Flow Recap: MSCI, CSI500, XIN9I, DTAC/TRUE, Newcrest, Adani, Korea Spinoffs

By Brian Freitas

  • MSCI announced the changes to the GIMI on Friday as part of the February QCIR. MSCI also announced a review of the free float of the Adani Group companies.
  • FTSE will announce the changes to the All-World and All-Cap indices after the close of trading on Friday, 17 February. The same day is the S&P/ASX review cutoff for March.
  • Yet another weekly outflow for the IShares Edge MSCI Min Vol Emerging Markets ETF (EEMV US) taking the YTD outflow to over US$2.5bn.

JGC (1963 JP) – A ToSTNeT Buyback Is NOT a ToSTNeT Buyback and Adjusted EV Vs Adjusted EBITDA Is OK.

By Travis Lundy

  • Engineering & Construction firm Jgc Corp (1963 JP) on Friday announced 9M results. Full-Year forecasts were revised, with revenue lowered, but OP, RP, and NP unchanged.
  • The company then also announced a ToSTNeT-3 buyback of up to 4.77% of shares out for ¥20bn to be executed Monday 13 February pre-open. But details matter. 
  • Four Important Takeaways: 1) sometimes a ToSTNeT-3 buyback is not a ToSTNeT-3 buyback, 2) that can be a good sign, and 3) sometimes Adjusted EV vs Adjusted EBITDA is OK.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Financials: Sabana Industrial REIT, JPY, Bajaj Finance Ltd, Berkshire Hathaway Inc Cl B and more

By | Daily Briefs, Financials

In today’s briefing:

  • Sabana Industrial REIT – Offer Goes Live, Worth A Look
  • Japan Watch: Kazuo Ueda – Who?
  • Bajaj Finance: Leveraging Its Platform to Deepen and Widen Its Product Penetration
  • Deep Dive: Japanese Trading Companies (Part 1)

Sabana Industrial REIT – Offer Goes Live, Worth A Look

By Travis Lundy

  • The Sabana Industrial REIT (SSREIT SP) 2022H2 dividend went ex- on 6 February 2023, setting the Offer to be lowered. The Offer by Volare was lowered. Docs out Friday night.
  • The S$0.465 Offer, adjusted for dividends (to be paid 27 March (cash or DRP units)), is now S$0.4504 per unit. The first close is 10 March 2023. 
  • Sabana has underperformed a basket of slightly higher beta peers by 1+% since the day before the announcement. Watch pro-ration risk.

Japan Watch: Kazuo Ueda – Who?

By Andreas Steno

  • Ueda seems like a centrist candidate compared to Amamiya (dove) or Yamaguchi (hawk)
  • Ueda, if he gets the nod on Tuesday, is likely to slowly but surely distance himself from YCC
  • We continue to like JPY on the prospects of tighter USD-JPY rates spreads 

Bajaj Finance: Leveraging Its Platform to Deepen and Widen Its Product Penetration

By Ankit Agrawal, CFA

  • Bajaj Finance Ltd (BAF IN) reported decent profitability. Growth was somewhat muted due to competition, however, this seems temporary.
  • The immediate focus of BAF to drive the next leg of growth is to deepen its product penetration across its existing branches. Currently, only 3% branches have 80%+ products.
  • BAF revealed its long-term strategic plan wherein it plans to enter into newer categories like Auto, Agri, and CV which comprise 28% of the Indian retail credit market.

Deep Dive: Japanese Trading Companies (Part 1)

By Value Punks

This is Part 1 of our exclusive deep dive on “Sogo Shosha”, or Japanese trading companies.

We’ve decided to break this deep dive into two parts given its length.

Part 1 will build the foundation and covers the business, history, and a discussion of Berkshire’s investment.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief India: Bajaj Finance Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Bajaj Finance: Leveraging Its Platform to Deepen and Widen Its Product Penetration

Bajaj Finance: Leveraging Its Platform to Deepen and Widen Its Product Penetration

By Ankit Agrawal, CFA

  • Bajaj Finance Ltd (BAF IN) reported decent profitability. Growth was somewhat muted due to competition, however, this seems temporary.
  • The immediate focus of BAF to drive the next leg of growth is to deepen its product penetration across its existing branches. Currently, only 3% branches have 80%+ products.
  • BAF revealed its long-term strategic plan wherein it plans to enter into newer categories like Auto, Agri, and CV which comprise 28% of the Indian retail credit market.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Japan: Jgc Corp, JPY, Tokyo Electron, Toshiba Corp, Tokyo Stock Exchange Tokyo Price Index Topix and more

By | Daily Briefs, Japan

In today’s briefing:

  • JGC (1963 JP) – A ToSTNeT Buyback Is NOT a ToSTNeT Buyback and Adjusted EV Vs Adjusted EBITDA Is OK.
  • Japan Watch: Kazuo Ueda – Who?
  • Tokyo Electron (8035 JP): MAGIC Versus Reality
  • Last Week in SPACE: Adani Group, Hongkong Land, Toshiba, Haw Par, Renault/Nissan
  • Weekly Deals Digest (12 Feb) – Pertamina Geothermal, Toshiba, Newcrest, Nitro, Boustead, Sabana
  • “Stable Dividend” Tradition May Have Something to Do with Rewarding Cross-Held Shareholders

JGC (1963 JP) – A ToSTNeT Buyback Is NOT a ToSTNeT Buyback and Adjusted EV Vs Adjusted EBITDA Is OK.

By Travis Lundy

  • Engineering & Construction firm Jgc Corp (1963 JP) on Friday announced 9M results. Full-Year forecasts were revised, with revenue lowered, but OP, RP, and NP unchanged.
  • The company then also announced a ToSTNeT-3 buyback of up to 4.77% of shares out for ¥20bn to be executed Monday 13 February pre-open. But details matter. 
  • Four Important Takeaways: 1) sometimes a ToSTNeT-3 buyback is not a ToSTNeT-3 buyback, 2) that can be a good sign, and 3) sometimes Adjusted EV vs Adjusted EBITDA is OK.

Japan Watch: Kazuo Ueda – Who?

By Andreas Steno

  • Ueda seems like a centrist candidate compared to Amamiya (dove) or Yamaguchi (hawk)
  • Ueda, if he gets the nod on Tuesday, is likely to slowly but surely distance himself from YCC
  • We continue to like JPY on the prospects of tighter USD-JPY rates spreads 

Tokyo Electron (8035 JP): MAGIC Versus Reality

By Scott Foster

  • The market welcomed TEL’s 3Q results and new guidance, but sales, profits and margins continue to decline year-on-year.
  • An optimistic consensus sees a new cyclical high in the second half of the decade, but avoids the question of disengagement from China.
  • Inventories are at a record high. Valuations out to FY Mar-25 do not look attractive. 

Last Week in SPACE: Adani Group, Hongkong Land, Toshiba, Haw Par, Renault/Nissan

By David Blennerhassett


Weekly Deals Digest (12 Feb) – Pertamina Geothermal, Toshiba, Newcrest, Nitro, Boustead, Sabana

By Arun George


“Stable Dividend” Tradition May Have Something to Do with Rewarding Cross-Held Shareholders

By Aki Matsumoto

  • The Nikkei article addresses high-dividend investing as short-term strategy, while “Quality Income” is in demand by long-term investors seeking stable long-term performance. Both strategies have different investor segments and needs.
  • Many Japanese companies have basic policy of “stable dividends,” but it is easier for shareholders seeking to increase shareholder interests to understand a dividend policy based on clear cash allocations.
  • Given that Metrical’s analysis also found no correlation between changes in market capitalization and dividend policy scores, linking dividends and stock price is a difficult problem.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ESG: “Stable Dividend” Tradition May Have Something to Do with Rewarding Cross-Held Shareholders and more

By | Daily Briefs, ESG

In today’s briefing:

  • “Stable Dividend” Tradition May Have Something to Do with Rewarding Cross-Held Shareholders

“Stable Dividend” Tradition May Have Something to Do with Rewarding Cross-Held Shareholders

By Aki Matsumoto

  • The Nikkei article addresses high-dividend investing as short-term strategy, while “Quality Income” is in demand by long-term investors seeking stable long-term performance. Both strategies have different investor segments and needs.
  • Many Japanese companies have basic policy of “stable dividends,” but it is easier for shareholders seeking to increase shareholder interests to understand a dividend policy based on clear cash allocations.
  • Given that Metrical’s analysis also found no correlation between changes in market capitalization and dividend policy scores, linking dividends and stock price is a difficult problem.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: ECM Weekly (12th Feb 2023) – Hesai and more

By | Daily Briefs, ECM

In today’s briefing:

  • ECM Weekly (12th Feb 2023) – Hesai, Oasis, Mankind, Greatpower, Ruipeng, CATL, Nissan/Renault
  • Ball Corporation: Details of Product Offerings & Key Drivers
  • Church & Dwight: Major Drivers
  • Corning Inc: Gorilla Glass Victus 2 & Other Developments
  • Exxon Mobil: Major Drivers

ECM Weekly (12th Feb 2023) – Hesai, Oasis, Mankind, Greatpower, Ruipeng, CATL, Nissan/Renault

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPO front, Hesai Group (HSAI US) provided the first Asia linked listing for the year.
  • Things were quiet on the placement front owing to the annual earnings reporting season.

Ball Corporation: Details of Product Offerings & Key Drivers

By Baptista Research

  • Ball’s performance in the quarter was extremely disappointing and the company missed out on meeting Wall Street expectations with respect to revenues as well as earnings.
  • The company did see a decent performance in EMEA aerospace and aerosol operations, especially in its newly constructed facilities in EMEA.
  • The management believes that Ball’s aerospace and aerosol segments are having ongoing success and will complement the activities of its global beverage operations.

Church & Dwight: Major Drivers

By Baptista Research

  • Church & Dwight delivered a strong set of results in the last quarter, with revenue growth of around 0.4% that was beyond Wall Street expectations.
  • Its international business delivered 3.2% organic growth, driven by impressive performance across international subsidiaries.
  • On the other hand, TROJAN condoms returned to share growth, while OXICLEAN stain removers and ARM & HAMMER baking soda achieved double-digit consumption growth.

Corning Inc: Gorilla Glass Victus 2 & Other Developments

By Baptista Research

  • Corning faced the impact of a series of pandemic-driven effects during the last quarter but the company managed to deliver an all-around beat.
  • The purchase of laptops, tablets, smartphones, televisions, and cars was below the company’s estimation in the last quarter.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Exxon Mobil: Major Drivers

By Baptista Research

  • Exxon Mobil delivered a mixed set of results for the last quarter.
  • The company’s cash flow performance was solid.
  • Exxon merged its downstream and chemical businesses to create Product Solutions, one of the world’s biggest fuels, chemicals, and lubricants companies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Thematic (Sector/Industry): Japan Weekly | Renesas and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Japan Weekly | Renesas, Mercari, Charts
  • GEM Weekly (10 Feb 2023): Indonesia, Thailand, India, China, Malaysia Macro; Samsung, Baidu, Kakao
  • SPAC Talk: The Peripheralization of De-SPACs

Japan Weekly | Renesas, Mercari, Charts

By Mark Chadwick

  • Global stocks generally headed lower in the week as investors fretted about the prospect of further Fed tightening. 
  • Japanese stocks eked out a small gain on strong domestic earnings and robust corporate outlooks. 
  • The yen strengthened after it was reported that Kazuo Ueda will be appointed as the next BoJ Governor. He is generally considered more hawkish than his predecessor. 

GEM Weekly (10 Feb 2023): Indonesia, Thailand, India, China, Malaysia Macro; Samsung, Baidu, Kakao

By Wium Malan, CFA

  • The Global Emerging Markets weekly provides a summary of the key news and related developments impacting the largest countries and constituents of the Global Emerging Markets equity indices.
  • Macro data points:Indonesia GDP, Thailand inflation, Indian interest rates, Chinese inflation, Malaysian GDP growth
  • Companies mentioned:Samsung Electronics (005930 KS), Baidu (9888 HK), Kakao Corp (035720 KS)

SPAC Talk: The Peripheralization of De-SPACs

By Water Tower Research

  • Deal terminations return to the spotlight. The past couple of months have seen a pickup in abandoned IBC deals.
  • Following nine deal cancelations in December, the second-highest monthly total in 2022 behind 10 in August, the first five weeks of 2023 have seen eight deals bite the dust—four in January and four in the first week of February.
  • There have been 69 deal terminations, with an aggregate deal value of ~$90 billion since the start of last year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars